Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: IL-17

Bimekizumab: Robust 1-year results in treating psoriatic arthritis

Presented By
Prof. Christopher Ritchlin, University of Rochester Medical Center, USA
Trial
Phase 3
Conference
ACR 2022

1 December, 2022 14:33

New treatments for HS: IL-17 inhibitors next in practice?

Presented By
Dr Axel Villani, University of Lyon, France & Prof. Thrasyvoulos Tzellos, Nordland Hospital Trust, Norway
Conference
SPIN 2022

26 August, 2022 10:05

Potential biomarker discovered for treatment response to ustekinumab

Presented By
Mr Shane Solanky, King’s College London, UK
Conference
PFGC 2021

3 February, 2022 15:46

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By
Dr Charlie Bridgewood, University of Leeds, UK
Conference
PFGC 2021

3 February, 2022 10:51

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By
Dr Ali Al-Janabi, University of Manchester, UK
Conference
PFGC 2021

2 February, 2022 15:22

Why antipsychotics cause weight gain

Presented By
Prof. Louise Gallagher, University of Dublin, Ireland
Conference
ECNP 2021

26 November, 2021 11:18

Existing and upcoming small molecules in psoriasis

Presented By
Dr Enikö Sonkoly , Karolinska University Hospital, Sweden
Trial
POETYK PSO; PSOARING
Conference
EADV 2021

18 November, 2021 13:19

Psoriatic arthritis: Guidelines and best practice

Trial
Phase 3, BE ACTIVE, PATERA
Conference
WPPAC 2021

17 September, 2021 11:19

Promising results with nanobody treatment in psoriasis

Presented By
Dr Kim A. Papp, Probity Medical Research, Canada
Trial
Phase 2
Conference
EADV 2020

17 December, 2020 13:40

Efficacious non-steroidal topical for psoriasis

Presented By
Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA
Trial
Phase 3, PSOARING
Conference
EADV 2020

17 December, 2020 13:28

AxSpA real-life remission rates higher on biologics

Presented By
Dr Charlotte Baert, Saint Luc University Hospital, Belgium
Conference
EULAR 2020

14 August, 2020 10:24

IL-17A and IL-17F blockade remarkably effective in psoriasis

Presented By
Prof. Kristian Reich; Prof. Kenneth B. Gordon
Trial
BE VIVID and BE READY
Conference
AAD 2020

6 August, 2020 07:09

Novel IL-23 blocker risankizumab highly effective and tolerable in psoriasis

Presented By
Prof. Richard B. Warren
Trial
IMMerge
Conference
AAD 2020

6 August, 2020 07:07

IL-17A blocker effective in paediatric psoriasis patients

Presented By
Dr Kim Papp, Probity Medical Research, Canada
Trial
Phase 3, IXORA-PEDS
Conference
EADV 2019

9 December, 2019 20:51

No hint of teratogenicity through ixekizumab

Presented By
Prof. Alexander Egeberg, Herlev and Gentofte Hospital, Denmark
Trial
PSOLAR
Conference
EADV 2019

9 October, 2019 14:32

Efficacy and safety of bimekizumab in patients with active PsA

Presented By
Dr Christopher Ritchlin, University of Rochester Medical Centre, USA
Trial
Phase 2, BE ACTIVE
Conference
EULAR 2019

4 September, 2019 11:10

Biologicals beyond TNF blockade

Presented By
Prof. Brian Kirby, St. Vincent’s University Hospital, Ireland
Conference
WCD 2019

26 August, 2019 11:11

Registries – an important research tool in biologics

Presented By
Prof. Bruce E. Strober, UConn Health, USA
Conference
WCD 2019

26 August, 2019 10:10

Advances in target-oriented therapy: psoriatic arthritis

Presented By
Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland
Trial
ECLIPSA, TICOPA
Conference
SPIN 2019

21 June, 2019 23:48

Understanding genetics to unravel psoriasis and atopic dermatitis pathogenesis

Presented By
Prof. Jonathan Barker, Kings College London, United Kingdom
Conference
SPIN 2019

21 June, 2019 20:34

Results from the ECLIPSE trial: does blocking IL-23 have better long-term outcomes in psoriasis?

Presented By
Prof. Kristian Reich, Georg-August-University Göttingen, Germany
Trial
ECLIPSE
Conference
SPIN 2019

21 June, 2019 18:23

Atopic dermatitis and psoriasis: on a spectrum?

Presented By
Prof. Emma Guttman-Yassky, Mount Sinai Medical School, USA
Conference
SPIN 2019

21 June, 2019 13:39

IBD risk of treatment with IL-17 antagonists

Presented By
Dr Wolfgang Eigner, Medical University of Vienna, Austria
Conference
ECCO 2019

9 May, 2019 14:37

Secukinumab maintains improvements in psoriasis through 5 years of treatment

Presented By
Prof. Richard Langley, Dalhousie University, Canada
Trial
ERASURE/FIXTURE
Conference
AAD 2019

19 April, 2019 23:10

Dual IL-17A and IL-17F blocker leads to unprecedented response rates in psoriasis

Presented By
Dr Andrew Blauvelt, Oregon Medical Research Center, USA
Trial
BE ABLE
Conference
AAD 2019

19 April, 2019 19:24

Psoriasis and Biologics: The Beat Goes On

Presented By
Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA
Conference
AAD 2019

19 April, 2019 14:06
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy